Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.78.

  • Vanda Pharmaceuticals' Equity Ratio fell 760.04% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78, marking a year-over-year decrease of 760.04%. This contributed to the annual value of 0.82 for FY2024, which is 233.72% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Equity Ratio of 0.78 as of Q3 2025, which was down 760.04% from 0.78 recorded in Q2 2025.
  • Vanda Pharmaceuticals' 5-year Equity Ratio high stood at 0.86 for Q1 2021, and its period low was 0.78 during Q3 2025.
  • Its 5-year average for Equity Ratio is 0.83, with a median of 0.83 in 2024.
  • In the last 5 years, Vanda Pharmaceuticals' Equity Ratio surged by 206.89% in 2023 and then plummeted by 760.04% in 2025.
  • Vanda Pharmaceuticals' Equity Ratio (Quarter) stood at 0.85 in 2021, then fell by 2.25% to 0.83 in 2022, then rose by 1.1% to 0.84 in 2023, then dropped by 2.34% to 0.82 in 2024, then decreased by 5.54% to 0.78 in 2025.
  • Its last three reported values are 0.78 in Q3 2025, 0.78 for Q2 2025, and 0.81 during Q1 2025.